Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichiro Nakajima

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 5, 2015
Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNOIsabelle Boileau, Shinichiro Nakajima, Doris Payer
JAMA|April 29, 2010
Depression severity and effect of antidepressant medicationsTakefumi Suzuki, Hiroyuki Uchida, Shinichiro Nakajima
CNS Spectrums|May 21, 2024
Real-world case series of maintenance theta burst stimulation therapy following response to acute theta burst stimulation therapy for difficult-to-treat depressionYoshihiro Noda, Kyoshiro Fujii, Shinichiro Nakajima, et al.
Psychiatry and Clinical Neurosciences|March 31, 2025
Medication equivalent dose program in RShinsuke Koike, Yoji Hirano, Shinichiro Nakajima, et al.
Journal of Alzheimer'S Disease : JAD|May 6, 2025
Correlations between agitation and other neuropsychiatric symptoms in each stage of Alzheimer's disease: A re-analysis of CATIE-ADTomoyuki Nagata, Shinichiro Nakajima, Shinsuke Kito, et al.
Neuropsychopharmacology Reports|September 13, 2023
Development of the Japanese version of the 30-item Mystical Experience QuestionnaireKengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, et al.
Frontiers in Psychiatry|November 3, 2022
Editorial: Prognostic imaging biomarkers in psychotic disordersDaiki Sasabayashi, Shinsuke Koike, Shinichiro Nakajima, et al.
Psychiatry and Clinical Neurosciences|December 18, 2023
Restarting smoking after discharge from clozapine inpatient initiation: Elevated rehospitalization rates smoking & clozapine rehospitalizationRyuhei So, Masaru Tsukahara, Shinichiro Nakajima, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|August 12, 2025
Programming literacy for physician-scientists in the AI eraRyoma Kani, Hidehiro Gon, Shinichiro Nakajima, et al.
Journal of Alzheimer'S Disease : JAD|August 30, 2024
The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer's Disease: A Re-Analysis of CATIE-ADTomoyuki Nagata, Shinichiro Nakajima, Shinsuke Kito, et al.
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 5, 2015
Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNOIsabelle Boileau, Shinichiro Nakajima, Doris Payer
JAMA|April 29, 2010
Depression severity and effect of antidepressant medicationsTakefumi Suzuki, Hiroyuki Uchida, Shinichiro Nakajima
CNS Spectrums|May 21, 2024
Real-world case series of maintenance theta burst stimulation therapy following response to acute theta burst stimulation therapy for difficult-to-treat depressionYoshihiro Noda, Kyoshiro Fujii, Shinichiro Nakajima, et al.
Psychiatry and Clinical Neurosciences|March 31, 2025
Medication equivalent dose program in RShinsuke Koike, Yoji Hirano, Shinichiro Nakajima, et al.
Journal of Alzheimer'S Disease : JAD|May 6, 2025
Correlations between agitation and other neuropsychiatric symptoms in each stage of Alzheimer's disease: A re-analysis of CATIE-ADTomoyuki Nagata, Shinichiro Nakajima, Shinsuke Kito, et al.
Neuropsychopharmacology Reports|September 13, 2023
Development of the Japanese version of the 30-item Mystical Experience QuestionnaireKengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, et al.
Frontiers in Psychiatry|November 3, 2022
Editorial: Prognostic imaging biomarkers in psychotic disordersDaiki Sasabayashi, Shinsuke Koike, Shinichiro Nakajima, et al.
Psychiatry and Clinical Neurosciences|December 18, 2023
Restarting smoking after discharge from clozapine inpatient initiation: Elevated rehospitalization rates smoking & clozapine rehospitalizationRyuhei So, Masaru Tsukahara, Shinichiro Nakajima, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|August 12, 2025
Programming literacy for physician-scientists in the AI eraRyoma Kani, Hidehiro Gon, Shinichiro Nakajima, et al.
Journal of Alzheimer'S Disease : JAD|August 30, 2024
The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer's Disease: A Re-Analysis of CATIE-ADTomoyuki Nagata, Shinichiro Nakajima, Shinsuke Kito, et al.
Pageof 23